Status: Recruiting
A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment
This study aims to evaluate the pharmacokinetic effects of a single dose of HRS-4729 injection in participants with mild, moderate, and severe renal impairment, with 8 participants enrolled in each renal impairment group and 8 healthy participants.
Participants needed: 32
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Fujian Shengdi Pharmaceutical Co., Ltd.Updated: Sep 16, 2026Locations: 1
Eligibility criteria
Provide written informed consent prior to any study-related procedures, and have... [+5]
Have a history of significant abnormal gastric emptying, severe gastrointestinal... [+26]